Unknown

Dataset Information

Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy?


ABSTRACT:

Background

Tolerability and antitumour efficacy of chemotherapy and radiation therapy can vary largely according to their time of administration along the 24-h time scale, due to the moderation of their molecular and cellular mechanisms by circadian rhythms. Recent clinical data have highlighted a striking role of dosing time for cancer immunotherapy, thus calling for a critical evaluation.

Methods

Here, we review the clinical data and we analyse the mechanisms through which circadian rhythms can influence outcomes on ICI therapies. We examine how circadian rhythm disorders can affect tumour immune microenvironment, as a main mechanism linking the circadian clock to the 24-h cycles in ICIs antitumour efficacy.

Results

Real-life data from 18 retrospective studies have

SUBMITTER: Karaboue A 

PROVIDER: S-EPMC11369086 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature